Releaf is a free mobile app that encourages patients to mindfully track their cannabis experiences. They believe you will strengthen your relationship with yourself while also learning how cannabis can help alleviate your specific issues and ailments. GRAM is proud to share with our readers data gathered using Releaf from individuals suffering from stress symptoms. 

They reported the effectiveness of products for specific symptoms of individuals suffering from anxiety, insomnia, agoraphobia, depression, PTSD, and gastrointestinal problems. The data reflect their individual experiences self-reported using the Releaf App.

---

Top Rated in USA

---

---

---

---

---

---

Top Rated in Florida

---

---

---

---

---

---

DOWNLOAD RELEAF APP TODAY TO TRACK, LEARN FROM, AND IMPROVE YOUR USE OF CANNABIS BY VISITING: releaf.at/GRAM

In case you missed the live video from our friends at Nugtopia, here it is! Jordan Person from Gram Magazine interviews Dr. Salm, a cannabis scientist that lived at an Antarctic Research station for 3 months! Covering terpenes, isolation and more…

Nugtopia 3 Pm

Jordan Person from Gram Magazine and Dr. Salm a cannabis scientist that lived at an Antarctic Research station for 2 years!

Posted by Tom Quigley on Monday, April 20, 2020

Dr. Russo comments in his latest editorial how the medical community has failed to appropriately manage chronic conditions such as pain and other debilitating diseases.

“The National Academies of Sciences, Engineering, and Medicine opined in 2017 that “there is conclusive or substantial evidence that cannabis or cannabinoids are effective: for the treatment of chronic pain in adults.”²

 Russo states that we need to face the facts:

– What doctors are currently using (opioids and non-opioids) is not effective in managing patients’ symptoms, and the lack of willingness tof many medical professionals to consider other options leaves the patients suffering.

– There is no longitudinal data that shows the efficacy of using opioids long term for chronic noncancer pain, and there is not much being developed in the drug market that aims to make any difference in how we currently treat patients.

 – Whether anyone likes it or not, increasingly millions of people around the globe are utilizing cannabis to treat their pain, and observational studies and surveys repeatedly demonstrate that pain is the top medical indication for cannabis usage, in the range of 70% of all patients.⁵

– No medication is deemed commercially successful unless the patient reports clinical improvements and perceives that they are improving due to the drug.

– There truly is no way to take an objective measurement of pain in the clinical field.

In order for anything in the medical/ biotechnology field to be taken seriously, there needs to be a randomized, double-blind placebo study with results that can be easily replicated and that is why cannabis has not been taken seriously for its therapeutic benefits. Due to the schedule 1 nature it makes it extremely difficult for researchers to do double-blind placebo studies. There is so much red tape on the subject that we are left with anecdotal evidence from patients along with the few clinical trials that are available using Sativex, the synthetic version of a 1:1 THC CBD oral mucosal spray.